<!doctype html>
<html>
    <head>
        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no">

        <title>reveal.js</title>

        <link rel="stylesheet" href="dist/reset.css">
        <link rel="stylesheet" href="dist/reveal.css">
        <link rel="stylesheet" href="dist/theme/black.css">

        <!-- Theme used for syntax highlighted code -->
        <link rel="stylesheet" href="plugin/highlight/monokai.css">
    </head>
    <body>
        <div class="reveal">
            <div class="slides">

                <section data-background-image="img/title_bg.jpg">
                    <h1 style="text-transform:none;background-color:rgba(0,0,0,0.3)">ALS genetics<br> <small>for the neurology registrar</small></h1>
                    <p style="background-color:rgba(0,0,0,0.3)">Evan Edmond<br>Neurology ST4<br>
                </section>

                <section data-background-image="img/tract_3d_iso.png" data-background-size="600px" data-background-repeat="repeat" data-background-opacity="0.2">
                    <h2>structure</h2>
                    <ul>
                        <li>Is ALS genetic?</li>
                        <li><em>C9orf72</em></li>
                        <li><em>SOD1</em></li>
                        <li><em>TARDBP</em></li>
                        <li>Others</li>
                        <li>What to do in the clinic</li>
                    </ul>
                </section>

                <section data-background-image="img/pea.jpg" data-background-opacity="0.1">
                    <h2>Is ALS genetic?
                    </h2>
                    <ul>
                        <li class="fragment">What have we learned from familial ALS?
                        </li>
                        <li class="fragment">How heritable is sporadic ALS?
                        </li>
                        <li class="fragment">Do we need a new model?</li>
                        </li>
                    </ul>
                </section>

                <section data-background-image="img/pedigree.png" data-background-opacity="0.4">
                    <h2>How common is familial ALS?
                    </h2>
                    <div style="float:left; width=75%">
                    <img src="img/fals_incidence.png" height="350">
                    <p>
                        <small>Byrne et. al. JNNP 2011.<br>
                            <a href="https://doi.org/10.1136/jnnp.2010.224501">doi
                            </a>
                        </small>
                    </p>
                    </div>
                    <div style="float:right; width=25%">
                        <ul>
                        <li class="fragment">Uncommon - 5-10%</li>
                        <li class="fragment">Geographically <strong>variable</strong></li>
                    </ul></div>
                </section>

                <section>
                    <div style="background-color:red; width:95%; float:left">Sporadic
                    </div>
                    <div style="background-color:green; width:5%; float:right">
                        <small>Fam
                        </small>
                    </div>
                    <ul class="fragment">
                        <p><br>Limitations of older studies</p>
                        <li class="fragment">guesswork with family history
                        </li>
                        <li class="fragment">clinical ALS only
                        </li>
                        <li class="fragment">variable definition of familial
                        </li>
                    </ul>
                </section>

                <section>
                    <p>Linkage studies in familial ALS have identified several key genes</p>
                    <div class="r-stack">
                        <div class="fragment fade-in-then-out">
                        <img alt="" src="img/sod1.png" height="400" />
                        <h2>SOD1</h2>
                        </div>
                        <div class="fragment fade-in-then-out">
                        <img alt="" src="img/tardbp_linkage.png"/>
                        <h2>TARDBP</h2>
                        </div>
                        <div class="fragment fade-in-then-out">
                        <img alt="" src="img/c9_link.png"/>
                        <h2>C9orf72</h2>
                        </div>
                    </div>
                </section>

                <section>
                    <h2 style="text-transform:none">How heritable is sporadic ALS?
                    </h2>
                    <p class="fragment">Twin studies - 60% <br> Al-Chalabi et. al. 2010 JNNP <a href="http://dx.doi.org/10.1136/jnnp.2010.207464">doi</a></p>
                </section>

                <section>
                    <h2>Family pairs in Irish register</h2>
                    <img src="img/family_pair.png"/>
                    <small>Ryan et. al. 2019 JAMA N <a href="https://www.doi.org/10.1001/jamaneurol.2019.2044">doi</a></small>
                </section>

                <section>
                    <h2>Germline monogenic causes only explain ~15% of apparently sporadic ALS</h2>
                    <img alt="" src="img/pies.jpg" height="350" />
                </section>

                <section data-auto-animate>
                    <h2>'Missing' heritability</h2>
                    <div data-id="1" style="background-color:red; width:95%; float:left">Sporadic
                    </div>
                    <div data-id="2" style="background-color:green; width:5%; float:right">
                        <small>Fam
                        </small>
                    </div>
                </section>

                <section data-auto-animate>
                    <h2>Do we need a new model?</h2>
                    <div data-id="1" style="background-image: linear-gradient(to right,red, orange); width:70%; float:left">Less heritable
                    </div>
                    <div data-id="2" style="background-image: linear-gradient(to right,orange, green); width:30%; float:right">
                        More heritable

                    </div>
                    <ul>
                        <li class="fragment">Mutations are not equivalent</li>
                        <li class="fragment">Currently unknown non-genetic modifiers of penetrance and severity</li>
                    </ul>
                </section>

                <section data-background-image="img/tract_3d_iso.png" data-background-size="600px" data-background-repeat="repeat" data-background-opacity="0.2">
                    <h2>structure</h2>
                    <ul>
                        <li style="color: gray">Is ALS genetic?</li>
                        <li><em>C9orf72</em></li>
                        <li><em>SOD1</em></li>
                        <li><em>TARDBP</em></li>
                        <li>Others</li>
                        <li>What to do in the clinic</li>
                    </ul>
                </section>

                <section data-background-image="img/bolt.jpg" data-background-opacity="0.1">
                    <h2>C9orf72 hexanucleotide repeat expansion</h2>
                        <img alt="" src="img/c9hre.png" height="200" />
                        <ul>
                            <li class="fragment">>30 repeats, can be thousands</li>
                            <li class="fragment">Does not show anticipation</li>
                            <li class="fragment">Repeat length (in blood) does not correlate with clinical features</li>
                            <li class="fragment">Likely somatic repeat instability</li>
                        </ul>

                </section>

                <section>
                    <h2>Mechanism - controversial</h2>
                    <ul class="fragment">
                        <li>Loss of function - vesicle trafficking/autophagy?</li>
                        <li>Toxic repeat RNA</li>
                        <li>Toxic repeat proteins</li>
                    </ul>
                    <img class="fragment" alt="" src="img/dpr.png"/>
                </section>

                <section>
                    <h2>Clinical features</h2>
                    <ul>
                        <li color="orange">Heterogeneous - ALS, FTD, or ALS+FTD</li>
                        <li>Emerging evidence - psychosis, bipolar, not cognitively normal before symptom onset</li>
                        <li>Family history - dementia unspecified?</li>
                    </ul>
                </section>

                <section>
                    <h2>Penetrance</h2>
                    <ul>
                        <li class="fragment">High (>90%) in the context of targeted testing in ALS/FTD clinics</li>
                        <li class="fragment">Healthy individuals carrying this mutation - ?0.15% <a href="https://doi.org/10.1016/j.ajhg.2013.01.011">Beck 2013</a></li>
                        <li class="fragment">Several other case reports of healthy older adults >80. Would they remain healthy?</li>
                    </ul>
                </section>

                <section>
                    <h2>Neuropathology</h2>
                    <img alt="" src="img/tdp43.png" height="400" />
                    <p>Similar (but not identical) distribution and morphology of TDP43 pathology to sporadic ALS.</p>
                </section>

                <section>
                    <img alt="" src="img/title_bg1.jpg"/>
                </section>

                <section>
                    <h2>Gene therapy trials in C9orf72</h2>
                    <ul>
                        <li class="fragment">Biogen trial - discontinued Mar 22</li>
                        <li class="fragment">No benefit, discontinued entire clinical program</li>
                        <li class="fragment">WAVE life sciences - ?recruiting since 2021 - Cambridge one site (Alex Murley)</li>
                        <li class="fragment">Need data published, huge scope for treatment refinement</li>

                    </ul>
                </section>

                <section data-background-image="img/sod1_bg.png" data-background-opacity="0.2">
                    <h2>SOD1</h2>
                    <ul>
                        <li class="fragment">Cu/Zn superoxide dismutase 1</li>
                        <li class="fragment">~200 reported variants</li>
                        <ul>
                            <li class="fragment">A4V - 50% in USA - aggressive course (survival 1y from diagnosis)</li>
                            <li class="fragment">heterozygous D90A - common polymorphism in Scandinavia - occasionally found in typical ALS</li>
                            <li class="fragment">homozygous D90A - slower disease course - up to 10y</li>
                        </ul>
                        <li class="fragment" style="color:orange">No FTD overlap</li>
                    </ul>
                </section>

                <section>
                    <h2>Neuropathology</h2>
                    <ul>
                        <li>no TDP43</li>
                    </ul>
                    <div class="r-stack">
                        <img class="fragment" alt="" src="img/tdp_spor.png" height="450" />
                        <img class="fragment" alt="" src="img/p62_sod1.png" height="450"/>
                    </div>
                </section>

                <section>
                    <img alt="" src="img/title_bg2.jpg"/>
                </section>

                <section>
                    <h2>Tofersen - <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2204705">VALOR trial</a></h2>
                    <div class="r-stack">
                        <div class="fragment fade-in-then-out">
                            <img alt="" src="img/valor_design.png" height="450" />
                            <p>+ open-label extension</p>
                        </div>
                        <div class="fragment fade-in-then-out">
                            <img alt="" src="img/valor_nfl.png" height="450" />
                            <p>Neurofilament light</p>
                        </div>
                        <div class="fragment fade-in-then-out">
                            <img alt="" src="img/valor_alsfrs.png" height="450" />
                            <p>Functional rating scale</p>
                        </div>
                    </div>
                </section>

                <section>
                    <h2>Trial limitations</h2>
                    <ul>
                        <li class="fragment">All SOD1 mutations included</li>
                        <li class="fragment">Did not meet primary endpoint</li>
                        <li class="fragment">Is suppressing all SOD1 (mutant and WT) a good idea?</li>
                        <li class="fragment">ATLAS trial in presymptomatic carriers of high-penetrance SOD1 mutations recruiting</li>
                    </ul>
                </section>

                <section data-background-image="img/tardbp_protein.png" data-background-opacity="0.2">
                    <h2>TARDBP</h2>
                    <ul>
                        <li class="fragment">DNA binding protein</li>
                        <li class="fragment">FTD, ALS or FTD+ALS</li>
                        <li class="fragment">Why are TARDBP mutations an uncommon cause of genetic ALS?</li>
                    </ul>
                </section>

                <section>
                    <h2>TARDBP for modelling ALS</h2>
                    <div class="r-stack">
                        <img alt="" src="img/tdp43_lcd.png" class="fragment fade-in-then-out"/>
                        <img alt="" src="img/tdp43_hydroph.png" class="fragment fade-in-then-out" height="450" />
                        <img alt="" src="img/tdp43_confocal.png" class="fragment" height="450"/>
                        <img alt="" src="img/tdp43_concept.png" class="fragment" height="450"/>
                    </div>
                    <p>Bolognesi et. al. Nature Comm 2019 <a href="https://doi.org/10.1038/s41467-019-12101-z">doi</a></p>
                </section>

                <section>
                    <img alt="" src="img/title_bg3.jpg"/>
                </section>

                <section data-background-image="img/fus.jpeg" data-background-opacity="0.2">
                    <h2>FUS</h2>
                    <ul>
                        <li class="fragment">RNA binding protein</li>
                        <li class="fragment">Young onset, aggressive ALS</li>
                        <li class="fragment">essential tremor, FTD too?</li>
                        <li class="fragment">Cytoplasmic aggregates, but not TDP43</li>
                    </ul>
                </section>


                <section>
                    <h2>Geographic variation</h2>
                    <div class="r-stack">
                        <img alt="" src="img/geography.png" height="600px" class="fragment"/>
                        <img alt="" src="img/geography2.png" height="600px"  class="fragment"/>
                    </div>
                </section>

                <section>
                    <h2>Other genes</h2>
                    <div class="r-stack">
                        <div class="fragment fade-in-then-out">
                            <img alt="" src="img/gene_timeline2.jpeg"/>
                            <small><p>Optimistic view</p></small>
                        </div>
                    <div class="fragment">
                    <img alt="" src="img/gene_timeline.png"/>
                    <small><p><a href="https://doi.org/10.1007/s40142-020-00194-8">Gregory et. al. 2020</a></p></small>
                    </div>
                    </div>
                </section>

                <section>
                    <h2>GWAS</h2>
                    <div class="r-stack">
                        <div class="fragment fade-in-then-out">
                    <img alt="" src="img/gwas.png" height="400" />
                    <small><p>Relatively few *common* variants</p></small>
                        </div>

                        <div class="fragment fade-in-then-out">
                    <img alt="" src="img/allelefreq.png" height="400" />
                    <small><p>Rare variants may account for more heritability in ALS vs. schizophrenia.</p></small>

                        </div>
                    </div>
                    <small><a href="https://pubmed.ncbi.nlm.nih.gov/27455348/">van Rheenen et. al. Nat Genet. 2016</a></small>
                </section>


                <section>
                    <h4>Modelling ALS incidence as a multistep process</h4>
                    <div class="r-stack">
                        <div class="fragment fade-in-then-out">
                        <img alt="" src="img/multistep.png"/>
                        <p>Sporadic ALS may be a 5 step process</p>
                        </div>
                        <div class="fragment">
                        <img alt="" src="img/multistep_gene.png"/>
                        <p>Genetic ALS may only be 2 or 3</p>
                        </div>
                    </div>
                    <small>
                        <p>
                            <a href="https://n.neurology.org/content/91/7/e635">Chio et. al. Neurology 2018</a>
                        </p>
                    </small>
                </section>


                <section data-background-image="img/tract_3d_iso.png" data-background-size="600px" data-background-repeat="repeat" data-background-opacity="0.2">
                    <h2>structure</h2>
                    <ul>
                        <li style="color: gray">Is ALS genetic?</li>
                        <li style="color: gray"><em>C9orf72</em></li>
                        <li style="color: gray"><em>SOD1</em></li>
                        <li style="color: gray"><em>TARDBP</em></li>
                        <li style="color: gray">Others</li>
                        <li>What to do in the clinic</li>
                    </ul>
                </section>

                <section>
                  <h2>Cases</h2>
                  <div class="r-stack">
                    <p class="fragment fade-in-then-out">
                      The two children of a patient with ALS without a wider family history accompany their parent (mother) to clinic.
                      After routine discussion about the causes of ALS, the patient expresses a wish to have all known genetic causes excluded.
                      One of the children becomes angry, saying not to do this as he does not want to find out that he is at an increased risk of
                      getting the disease.
                    </p>
                    <p class="fragment fade-in-then-out">
                      A 16-­week pregnant woman with ALS without a family history requests rapid genetic testing to guide termina-
                      tion if an ALS gene variant is found.
                    </p>
                    <p class="fragment fade-in-then-out">
                      A 30-­year-­old patient with ALS but without a family history requests genetic testing and is found to have a
                      C9ORF72 hexanucleotide repeat expansion. At a subsequent appointment, the patient is accompanied by both parents, who
                      are asymptomatic.
                    </p>
                    <p class="fragment fade-in-then-out">
                      A patient with ALS without a family history and with a lower motor neurone-­predominant phenotype arranges
                      private whole-­genome sequencing, which reports a variant of uncertain significance in ABCD1. The patient is concerned that
                      they have been misdiagnosed.
                    </p>
                    <p class="fragment fade-in-then-out">
                      A patient with ALS without a family history and with a typical progression rate has read about gene-­targeting
                      trials in SOD1-­mediated ALS. They request genetic testing so that they might be eligible to enrol. It reveals that they are heterozygous for a ‘likely pathogenic’ variant associated with a characteristically very slowly progressive, typically homozygous recessive form of ALS.
                    </p>
                    <p class="fragment fade-in-then-out">
                      A patient with ALS without a family history and with a lower motor neurone-­predominant phenotype arranges
                      private whole-­genome sequencing, which reports a variant of uncertain significance in ABCD1. The patient is concerned that
                      they have been misdiagnosed.
                    </p>
                  </div>

                </section>

                <section>
                    <h2>Phenotype</h2>
                    <ul>
                        <li class="fragment" style="color:orange">ALS remains largely a clinical diagnosis</li>
                        <li>Spectrum - pure motor, pure cog, both</li>
                        <li>Age of onset</li>
                        <li>Rate of progression</li>
                        <li class="fragment" style="color:orange">weak predictors</li>
                    </ul>
                </section>

                <section>
                    <h2>Family history</h2>
                    <p>Not just ALS</p>
                    <ul>
                        <li class="fragment">Lost weight, mobility/speech declined rapidly at end of life?</li>
                        <li class="fragment">Dementia - AD misdiagnosed?</li>
                        <li class="fragment">Alcohol abuse, bipolar, schizophrenia?</li>
                        <li class="fragment">Chestnuts - adoption, non-paternity, consanguinity</li>
                    </ul>
                </section>

                <section>
                    <img alt="" src="img/pedigree2.png"/>
                </section>

                <section>
                    <h2>When to discuss genetics?</h2>
                    <ul>
                        <li class="fragment">Patient wants to know - Easier, may need specialist input</li>
                        <li class="fragment">Patient doesn't want to know - Difficult, clinical judgement</li>
                        <li class="fragment">Patient hasn't thought about it - Difficult, clinical judgement</li>
                        <li class="fragment">Research/clinical trial access</li>
                        <li class="fragment">With discretion/at patient request at diagnosis, mainly in followup</li>
                    </ul>
                </section>

                <section>
                    <h2>Other considerations</h2>
                    <ul>
                        <li class="fragment">Capacity - tricky - does mild impulsivity affect capacity?</li>
                        <li class="fragment">Family dynamics - beware the anxious healthy biological relative who has read up</li>
                    </ul>
                </section>

                <section>
                    <h2>Testing - ALS patients</h2>
                    <ul>
                        <li class="fragment">DNA storage</li>
                        <ul class="fragment">
                            <li style="color:gray">Targeted genes</li>
                            <li style="color:gray">Panel</li>
                            <li style="color:orange">WGS virtual panel</li>
                        </ul>
                    </ul>
                </section>

                <section data-background-image="img/r58.png" data-background-size="800px">
                    <p>R58</p>
                </section>

                <section>
                    <h2>WGS considerations</h2>
                    <ul>
                        <li class="fragment">433 entities - 97 green</li>
                        <li class="fragment">Many non-ALS genes</li>
                        <li class="fragment">Privacy and research participation</li>
                        <li class="fragment">Consent and recording</li>
                    </ul>
                </section>

                <section>
                    <h2><a href="https://www.england.nhs.uk/publication/nhs-genomic-medicine-service-test-order-forms/">NHS genomics forms</a></h2>
                    <div class="r-stack">
                        <img alt="" src="img/genomics_form.png" height="600px" class="fragment"/>
                        <img alt="" src="img/genomics_rod_form.png" height="600px"  class="fragment"/>
                    </div>
                </section>

                <section>
                <h2>Interpreting results</h2>
                <div class="r-stack">
                    <img alt="" src="img/panels.png" height="500px"  class="fragment"/>
                    <img alt="" src="img/genetic_results.png" height="500px" class="fragment"/>
                    <img alt="" src="img/actionable.png" height="500px"  class="fragment"/>
                </div>
                <small>
                    <p>
                        <a href="https://doi.org/10.1093/brain/awac279">Mehta et. al. Brain 2022</a>
                    </p>
                </small>
                </section>

                <section>
                    <h2>Example result</h2>
                    <img alt="" src="img/result.png" class="fragment"/>
                </section>

                <section>
                  <h2>Disclosing genetic testing results</h2>
                  <ul>
                    <li class="fragment">Patients generally disclose once they have processed</li>
                    <li class="fragment">Patients can nominate relatives to have access to results after death</li>
                    <li class="fragment">Get genetics advice if patient refuses to disclose/otherwise believe at risk</li>
                    <li class="fragment">Occupational implications</li>
                    <li class="fragment">Health insurance - insurers can request Huntington's predictive test results</li>
                  </ul>

                </section>
                <section>
                    <h2>tl;dr</h2>
                    <ul>
                        <li class="fragment">"actionable" genetics in 10-20% of ALS</li>
                        <li class="fragment">This will likely increase in proportion and complexity</li>
                        <li class="fragment">Genetics can be discussed with all ALS patients</li>
                        <li class="fragment">Testing is evolving - locally we use WGS virtual panel</li>
                        <li class="fragment">Thought/care with results</li>
                        <li class="fragment">Specialist ALS/FTD and genetics services exist</li>
                    </ul>
                </section>


                <section data-background-image="img/tract_3d_iso.png" data-background-size="600px" data-background-repeat="repeat" data-background-opacity="0.2">
                    <h2>structure</h2>
                    <ul>
                        <li>Is ALS genetic?</li>
                        <li><em>C9orf72</em></li>
                        <li><em>SOD1</em></li>
                        <li><em>TARDBP</em></li>
                        <li>Others</li>
                        <li>What to do in the clinic</li>
                    </ul>
                </section>

                <section data-background-image="img/question.gif">

                </section>

            </div>
        </div>

        <script src="dist/reveal.js"></script>
        <script src="plugin/notes/notes.js"></script>
        <script src="plugin/markdown/markdown.js"></script>
        <script src="plugin/highlight/highlight.js"></script>
        <script>
         // More info about initialization & config:
         // - https://revealjs.com/initialization/
         // - https://revealjs.com/config/
         Reveal.initialize({
             hash: true,

             // Learn about plugins: https://revealjs.com/plugins/
             plugins: [ RevealMarkdown, RevealHighlight, RevealNotes ]
         });
        </script>
    </body>
</html>
